Admission Date:  [**2181-2-8**]              Discharge Date:   [**2181-2-9**]

Date of Birth:  [**2118-5-23**]             Sex:   M

Service: MEDICINE

Allergies:
Penicillins / Ace Inhibitors / Acebutolol / Atenolol / Betaxolol
/ Bisoprolol / Carvedilol / Labetalol / Metoprolol / Nadolol /
Penbutolol / Pindolol / Propranolol / Timolol

Attending:[**First Name3 (LF) 425**]
Chief Complaint:
Infected [**Hospital1 **]-V ICD leads and device

Major Surgical or Invasive Procedure:
s/p ICD lead and device extraction on [**2181-2-8**]


History of Present Illness:
62 year old male patient of Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 26237**], Dr. [**First Name8 (NamePattern2) **]
[**Last Name (NamePattern1) 5051**], and Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] who has an extensive past
medical history including non-ischemic cardiomyopathy with an EF
15-20%, s/p initial implantation of an ICD in [**2175**] and a BiV
lead upgrade in [**2179-8-21**].  Following the lead upgrade, the
patient developed an erosion of the overlying skin which was
complicated by an infection in the device pocket.  The pocket
was debrided on [**2180-8-18**].  Since that time, the patient
has required multiple courses of antibiotics, both intravenous
and oral.  He is currently taking a 3-week course of oral
cephalexin.  He was referred for extraction of the ICD leads and
device.

Past Medical History:
Past Medical History:
1.  Nonischemic cardiomyopathy, chronic systolic heart failure.
2.  Mitral regurgitation with pulmonary hypertension.
3.  Ventricular tachycardia s/p ICD implantation [**2175**]
4.  COPD.
5.  Morbid obesity.
6.  Spinal stenosis.
7.  Right malignant renal tumor, s/p right nephrectomy
8.  Stage 4 chronic renal failure.
9.  Hypertension.
10. Leg ulcers.
11. Gout

Other Past Surgeries:  laparoscopic cholecystectomy in [**2174**],
mini
thoracotomy [**8-27**], hernia repair.


Social History:
The patient is a disabled former truck driver who currently
helps run a home daycare center.  He is married with adult
children and lives with his wife.  [**Name (NI) **] quit smoking at age 35.
No alcohol,no drugs.


Family History:
No family history of premature CAD, sudden cardiac death, or
arryhtmias.  His father has a history of a cerebral hemmorhage.


Physical Exam:
General: Obese white male in no acute distress lying in bed.
Neuro: Alert and oriented  to person, place, and time.
Cardiac: Regular rate and rhythm.  Normal S1,S2. No
murmurs/rubs/gallops.
Resp: Lungs are diminished throughout.
GI: Abdomen is large and softly distended.  Bowel sounds are
present.
GU: Voids concentrated yellow urine.
Integ: Left chest incision is covered with dry sterile dressing.
 Surrounding skin is reddened.  No drainage noted.
Periph vasc: Right femoral vein access site is intact.  No
hematoma or bruit. Distal pulses are present.  Bilateral lower
extremities are scaly, dusky, and dry.  Feet are warm with
decreased sensation.  Right ankle ulcer is approximately [**12-22**]
inch and no drainage is noted.

Pertinent Results:
[**2181-2-9**] 05:20AM BLOOD WBC-9.0 RBC-4.05* Hgb-11.2* Hct-34.8*
MCV-86 MCH-27.7 MCHC-32.2 RDW-15.6* Plt Ct-203
[**2181-2-9**] 05:20AM BLOOD Plt Ct-203
[**2181-2-9**] 05:20AM BLOOD UreaN-54* Creat-3.1*

Brief Hospital Course:
ICD site infection: Patient was admitted to [**Hospital1 **] on [**2181-2-8**] and underwent extraction of ICD lead and
device.  He was admitted to the inpatient cardiac unit for
observation and continuous cardiac monitoring.  He was continued
on all of his home medications.  Oral cephalexin was continued
as part of 3-week outpatient course.  The patient remained
afebrile with all vital signs stable during his hospitalization.

Stage 4 chronic renal failure: Patient has a history of a
malignant right renal tumor and a right nephrectomy [**2180-3-21**].
Creatinine at admission was 3.4 and on [**2-9**] was 3.1.

Right foot ulcer: Patient has history of right ankle skin graft
[**2180-2-19**] for a non-healing ulcer.  An open area that remains
is approximately [**12-22**] inch and was evaluated by a wound/ostomy
nurse.  Dressing changes were recommended and should be
continued after transfer.

Medications on Admission:
1. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:
One (1) puff Inhalation [**Hospital1 **] (2 times a day).
2. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable
PO DAILY (Daily).
3. Lasix 80 mg Tablet Sig: one and a half  Tablet PO twice a
day.
4. Imdur 30 mg Tablet Sustained Release 24 hr Sig: Three (3)
Tablet Sustained Release 24 hr PO once a day.
5. Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).

6. Quinidine Gluconate 324 mg Tablet Sustained Release Sig: Two
(2) Tablet Sustained Release PO QAM (once a day (in the
morning)).
7. Quinidine Gluconate 324 mg Tablet Sustained Release Sig: One
(1) Tablet Sustained Release PO BID (2 times a day): one tablet
in afternoon and one tablet in evening, in addition to two
tablets in the morning .
8. Cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q12H (every
12 hours).
9. Mexiletine 200 mg Capsule Sig: Two (2) Capsule PO QAM (once a
day (in the morning)).
10. Mexiletine 200 mg Capsule Sig: One (1) Capsule PO BID (2
times a day): one capsule in the afternoon and one capsule in
the evening in addition to two capsules every morning.
11. Hydralazine 50 mg Tablet Sig: One (1) Tablet PO TID (3 times
a day).
12. Potassium Chloride 20 mEq Tab Sust.Rel. Particle/Crystal
Sig: One (1) Tab Sust.Rel. Particle/Crystal PO DAILY (Daily).
13. Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
14. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1)
Spray Nasal DAILY (Daily).


Discharge Medications:
1. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:
One (1) puff Inhalation [**Hospital1 **] (2 times a day).
2. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable
PO DAILY (Daily).
3. Lasix 80 mg Tablet Sig: one and a half  Tablet PO twice a
day.
4. Imdur 30 mg Tablet Sustained Release 24 hr Sig: Three (3)
Tablet Sustained Release 24 hr PO once a day.
5. Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).

6. Quinidine Gluconate 324 mg Tablet Sustained Release Sig: Two
(2) Tablet Sustained Release PO QAM (once a day (in the
morning)).
7. Quinidine Gluconate 324 mg Tablet Sustained Release Sig: One
(1) Tablet Sustained Release PO BID (2 times a day): one tablet
in afternoon and one tablet in evening, in addition to two
tablets in the morning .
8. Cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q12H (every
12 hours).
9. Mexiletine 200 mg Capsule Sig: Two (2) Capsule PO QAM (once a
day (in the morning)).
10. Mexiletine 200 mg Capsule Sig: One (1) Capsule PO BID (2
times a day): one capsule in the afternoon and one capsule in
the evening in addition to two capsules every morning.
11. Hydralazine 50 mg Tablet Sig: One (1) Tablet PO TID (3 times
a day).
12. Potassium Chloride 20 mEq Tab Sust.Rel. Particle/Crystal
Sig: One (1) Tab Sust.Rel. Particle/Crystal PO DAILY (Daily).
13. Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
14. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1)
Spray Nasal DAILY (Daily).


Discharge Disposition:
Extended Care

Facility:
[**Hospital3 105**] Northeast - [**Location (un) 1110**]

Discharge Diagnosis:
s/p ICD lead and device extraction secondary to infected pocket

Discharge Condition:
Vitals: 97.3 - 93/48 - 76 - 20 - 95% on room air
Labs: BUN 54 Cre 3.1 WBC 9.0  Hgb 11.2  Hct 34.8  Plt 203
Neuro: Alert and oriented X 3.
Cardiac: Regular rate and rhythm.  Normal S1,S2.  No murmurs
appreciated.
Respiratory: Lungs are diminished throughout.
Peripheral vascular: Right femoral vein access site intact.  No
bleeding, hematoma, or bruit.  Distal pulses are present.
Skin: Left chest wall incision is intact and covered with a dry,
sterile dressing.  Surrounding skin has considerable erythema,
but scant drainage.


Discharge Instructions:
Continue your current medications as prescribed.  It is
important that you complete your 3-week course of Cephalexin.

Keep your chest dressing dry.  The nurses at the rehabilitation
facility